Rezolute, Inc. (RZLT)
3.34
+0.12
(+3.73%)
USD |
NASDAQ |
May 21, 16:00
3.35
+0.01
(+0.30%)
After-Hours: 19:59
Rezolute Research and Development Expense (TTM) : 59.77M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| XOMA Royalty Corp. | 0.468M |
| SELLAS Life Sciences Group, Inc. | 17.95M |
| ADMA Biologics, Inc. | 6.532M |
| Krystal Biotech, Inc. | 54.64M |